These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10921770)

  • 1. Computer-aided design and activity prediction of leucine aminopeptidase inhibitors.
    Grembecka J; Sokalski WA; Kafarski P
    J Comput Aided Mol Des; 2000 Aug; 14(6):531-44. PubMed ID: 10921770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
    Grembecka J; Mucha A; Cierpicki T; Kafarski P
    J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding structure of the leucine aminopeptidase inhibitor microginin FR1.
    Kraft M; Schleberger C; Weckesser J; Schulz GE
    FEBS Lett; 2006 Dec; 580(30):6943-7. PubMed ID: 17157838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition state analogue L-leucinephosphonic acid bound to bovine lens leucine aminopeptidase: X-ray structure at 1.65 A resolution in a new crystal form.
    Sträter N; Lipscomb WN
    Biochemistry; 1995 Jul; 34(28):9200-10. PubMed ID: 7619821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Silico Screening for Novel Leucine Aminopeptidase Inhibitors with 3,4-Dihydroisoquinoline Scaffold.
    Ziemska J; Solecka J; Jarończyk M
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32290229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-metal ion mechanism of bovine lens leucine aminopeptidase: active site solvent structure and binding mode of L-leucinal, a gem-diolate transition state analogue, by X-ray crystallography.
    Sträter N; Lipscomb WN
    Biochemistry; 1995 Nov; 34(45):14792-800. PubMed ID: 7578088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure determination and refinement of bovine lens leucine aminopeptidase and its complex with bestatin.
    Burley SK; David PR; Sweet RM; Taylor A; Lipscomb WN
    J Mol Biol; 1992 Mar; 224(1):113-40. PubMed ID: 1548695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and mechanism of bovine lens leucine aminopeptidase.
    Kim H; Lipscomb WN
    Adv Enzymol Relat Areas Mol Biol; 1994; 68():153-213. PubMed ID: 8154324
    [No Abstract]   [Full Text] [Related]  

  • 9. Leucine aminopeptidase as a target for inhibitor design.
    Grembecka J; Kafarski P
    Mini Rev Med Chem; 2001 Jul; 1(2):133-44. PubMed ID: 12369979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-refinement of the X-ray crystal structure of bovine lens leucine aminopeptidase complexed with bestatin.
    Kim H; Burley SK; Lipscomb WN
    J Mol Biol; 1993 Apr; 230(3):722-4. PubMed ID: 8478928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
    Chaudhary M; Singh V; Anvikar AR; Sahi S
    Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a working model of the active site in bovine lens leucine aminopeptidase: a density functional investigation.
    Erhardt S; Weston J
    Chembiochem; 2002 Jan; 3(1):101-4. PubMed ID: 17590960
    [No Abstract]   [Full Text] [Related]  

  • 13. Modelling of human leucyl aminopeptidases for in silico off target binding analysis of potential Plasmodium falciparum leucine aminopeptidase (PfA-M17) specific inhibitors.
    Sahi S; Raj U; Chaudhary M; Nain V
    Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(3):191-201. PubMed ID: 25269653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine-lens leucine aminopeptidase. Kinetic studies with substrates and substrate-like inhibitors.
    Fittkau S; Förster U; Pascual C; Schunck WH
    Eur J Biochem; 1974 May; 44(2):523-8. PubMed ID: 4838681
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases.
    Vassiliou S; Węglarz-Tomczak E; Berlicki Ł; Pawełczak M; Nocek B; Mulligan R; Joachimiak A; Mucha A
    J Med Chem; 2014 Oct; 57(19):8140-51. PubMed ID: 25192493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phosphonamidate containing aromatic N-terminal amino group as inhibitor of leucine aminopeptidase-design, synthesis and stability.
    Mucha A; Kunert A; Grembecka J; Pawełczak M; Kafarski P
    Eur J Med Chem; 2006 Jun; 41(6):768-72. PubMed ID: 16690170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A water sluice is generated in the active site of bovine lens leucine aminopeptidase.
    Erhardt S; Jaime E; Weston J
    J Am Chem Soc; 2005 Mar; 127(11):3654-5. PubMed ID: 15771473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of bovine lens leucine aminopeptidase by bestatin: number of binding sites and slow binding of this inhibitor.
    Taylor A; Peltier CZ; Torre FJ; Hakamian N
    Biochemistry; 1993 Jan; 32(3):784-90. PubMed ID: 8422382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical characterization and structural prediction of a novel cytosolic leucyl aminopeptidase of the M17 family from Schizosaccharomyces pombe.
    Herrera-Camacho I; Rosas-Murrieta NH; Rojo-Domínguez A; Millán L; Reyes-Leyva J; Santos-López G; Suárez-Rendueles P
    FEBS J; 2007 Dec; 274(23):6228-40. PubMed ID: 18028193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine-lens leucine aminopeptidase. Kinetic studies with activators and competitive inhibitors.
    Lasch J; Kudernatsch W; Hanson H
    Eur J Biochem; 1973 Apr; 34(1):53-7. PubMed ID: 4735658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.